Podcast interview with OraSure COO/CFO Ron Spair

[audio http://website.guild.im/williams/wp-content/uploads/sites/17/2009/04/orasure3.mp3]
OraSure Technologies develops and markets point-of-care oral fluid diagnostic tests for HIV and other diseases. In this podcast I interview Ron Spair, OraSure's COO and CFO, about the shift to routine HIV testing.The CDC issued guidelines recommending routine testing back in 2006, and uptake has been somewhat slow. That's changing thanks to activities such as the Forum for Collaborative HIV Research's recent Summit on HIV Diagnosis, Prevention and Access to Care.Ron and I spoke about the CDC guidelines and their impact on the HIV testing marketing, the outlook for reimbursement, and the role of quick turnaround tests such as OraSure's OraQuick Advance HIV 1/2 Antibody test.